Literature DB >> 30626686

Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High TFH:TFR Ratios Drive Induction of Potent Neutralizing Antibody Responses.

Preethi Eldi1, Geeta Chaudhri1, Stephen L Nutt2,3, Timothy P Newsome4, Gunasegaran Karupiah5,6.   

Abstract

Live viral vaccines elicit protective, long-lived humoral immunity, but the underlying mechanisms through which this occurs are not fully elucidated. Generation of affinity matured, long-lived protective antibody responses involve close interactions between T follicular helper (TFH) cells, germinal center (GC) B cells, and T follicular regulatory (TFR) cells. We postulated that escalating concentrations of antigens from replicating viruses or live vaccines, spread through the hematogenous route, are essential for the induction and maintenance of long-lived protective antibody responses. Using replicating and poorly replicating or nonreplicating orthopox and influenza A viruses, we show that the magnitude of TFH cell, GC B cell, and neutralizing antibody responses is directly related to virus replicative capacity. Further, we have identified that both lymphoid and circulating TFH:TFR cell ratios during the peak GC response can be used as an early predictor of protective, long-lived antibody response induction. Finally, administration of poorly or nonreplicating viruses to allow hematogenous spread generates significantly stronger TFH:TFR ratios and robust TFH, GC B cell and neutralizing antibody responses.IMPORTANCE Neutralizing antibody response is the best-known correlate of long-term protective immunity for most of the currently licensed clinically effective viral vaccines. However, the host immune and viral factors that are critical for the induction of robust and durable antiviral humoral immune responses are not well understood. Our study provides insight into the dynamics of key cellular mediators of germinal center reaction during live virus infections and the influence of viral replicative capacity on the magnitude of antiviral antibody response and effector function. The significance of our study lies in two key findings. First, the systemic spread of even poorly replicating or nonreplicating viruses to mimic the spread of antigens from replicating viruses due to escalating antigen concentration is fundamental to the induction of durable antibody responses. Second, the TFH:TFR ratio may be used as an early predictor of protective antiviral humoral immune responses long before memory responses are generated.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  T follicular helper cells; T follicular regulatory cells; germinal center B cells; hematogenous viral spread; inactivated vaccines; influenza A viruses; live vaccines; long-lived antibody response; neutralizing antibodies; orthopoxviruses

Mesh:

Substances:

Year:  2019        PMID: 30626686      PMCID: PMC6401457          DOI: 10.1128/JVI.01795-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Authors:  Cindy S Ma; Danielle T Avery; Anna Chan; Marcel Batten; Jacinta Bustamante; Stephanie Boisson-Dupuis; Peter D Arkwright; Alexandra Y Kreins; Diana Averbuch; Dan Engelhard; Klaus Magdorf; Sara S Kilic; Yoshiyuki Minegishi; Shigeaki Nonoyama; Martyn A French; Sharon Choo; Joanne M Smart; Jane Peake; Melanie Wong; Paul Gray; Matthew C Cook; David A Fulcher; Jean-Laurent Casanova; Elissa K Deenick; Stuart G Tangye
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo.

Authors:  Hisaya Akiba; Kazuyoshi Takeda; Yuko Kojima; Yoshihiko Usui; Norihiro Harada; Tomohide Yamazaki; Juan Ma; Katsunari Tezuka; Hideo Yagita; Ko Okumura
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

Review 3.  Germinal center enhancement by extended antigen availability.

Authors:  Kimberly M Cirelli; Shane Crotty
Journal:  Curr Opin Immunol       Date:  2017-07-21       Impact factor: 7.486

4.  ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells.

Authors:  Lukas Bossaller; Jan Burger; Ruth Draeger; Bodo Grimbacher; Rolf Knoth; Alessandro Plebani; Anne Durandy; Ulrich Baumann; Michael Schlesier; Andrew A Welcher; Hans Hartmut Peter; Klaus Warnatz
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation.

Authors:  André Ballesteros-Tato; Beatriz León; Beth A Graf; Amy Moquin; Pamela Scott Adams; Frances E Lund; Troy D Randall
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

6.  Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling.

Authors:  Marcel Jonges; Wai Ming Liu; Erhard van der Vries; Ronald Jacobi; Inge Pronk; Claire Boog; Marion Koopmans; Adam Meijer; Ernst Soethout
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

7.  Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence.

Authors:  G V Kochneva; I H Urmanov; E I Ryabchikova; V V Streltsov; O I Serpinsky
Journal:  Virus Res       Date:  1994-10       Impact factor: 3.303

8.  Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression.

Authors:  Martin Vaeth; Gerd Müller; Dennis Stauss; Lena Dietz; Stefan Klein-Hessling; Edgar Serfling; Martin Lipp; Ingolf Berberich; Friederike Berberich-Siebelt
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

9.  Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection.

Authors:  Davide Botta; Michael J Fuller; Tatiana T Marquez-Lago; Holly Bachus; John E Bradley; Amy S Weinmann; Allan J Zajac; Troy D Randall; Frances E Lund; Beatriz León; André Ballesteros-Tato
Journal:  Nat Immunol       Date:  2017-09-11       Impact factor: 25.606

10.  Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.

Authors:  Ram P Kamal; Kristy Blanchfield; Jessica A Belser; Nedzad Music; Wen-Pin Tzeng; Crystal Holiday; Ashley Burroughs; Xiangjie Sun; Taronna R Maines; Min Z Levine; Ian A York
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more
  2 in total

1.  Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection.

Authors:  Priyadharshini Devarajan; Allen M Vong; Catherine H Castonguay; Olivia Kugler-Umana; Bianca L Bautista; Michael C Jones; Karen A Kelly; Jingya Xia; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 12.779

Review 2.  Follicular regulatory T cells: a novel target for immunotherapy?

Authors:  Yao Huang; Zhe Chen; Hui Wang; Xin Ba; Pan Shen; Weiji Lin; Yu Wang; Kai Qin; Ying Huang; Shenghao Tu
Journal:  Clin Transl Immunology       Date:  2020-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.